Clinical Trial Update: An Ascending Multi-Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers [Phase 1]

View source ↗

Summary

Phase 1 ascending multi-dose tolerance and pharmacokinetic study in overweight/obese individuals with type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Genaera Corporation | Conditions: Diabetes Mellitus, Obesity | Phase 1 | Status: COMPLETED